rindopepimut injectable peptide cancer targets mutant protein called egfrviii present glioblastoma vaccine consists peptide acid mutant viii conjugated nonspecific immunomodulator keyhole limpet hemocyanin us fda granted breakthrough therapy designation glioblastoma feb meaning might able get approval sooner phase ii act iii study reported encouraging results june react clinical trial glioblastoma reported encouraging results march phase iii act iv trial terminated increase overall pharmacologyrelated article stub help wikipedia expanding httpsenwikipediaorgwikirindopepimut